These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19553638)

  • 21. A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
    González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Sanzo C; Aventín A; Puiggros A; Collado R; Heras C; Muñoz C; Delgado J; Ortega M; González MT; Marugán I; de la Fuente I; Recio I; Bosch F; Espinet B; González M; Hernández-Rivas JM; Hernández JÁ; ;
    Hematol Oncol; 2016 Jun; 34(2):84-92. PubMed ID: 25689772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of young CLL patients: a single-centre experience from Turkey.
    Pamuk GE; Pamuk ON; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Haematologia (Budap); 2002; 31(4):303-11. PubMed ID: 12038513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults.
    Montserrat E; Gomis F; Vallespí T; Ríos A; Romero A; Soler J; Alcalá A; Morey M; Ferrán C; Díaz-Mediavilla J
    Blood; 1991 Sep; 78(6):1545-51. PubMed ID: 1884021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
    Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.
    Hock BD; McKenzie JL; McArthur L; Tansley S; Taylor KG; Fernyhough LJ
    Intern Med J; 2010 Dec; 40(12):842-9. PubMed ID: 20002855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Pulte D; Redaniel MT; Bird J; Jeffreys M
    Eur J Haematol; 2015 Jun; 94(6):540-5. PubMed ID: 25315799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.
    Apelgren P; Hasselblom S; Werlenius O; Nilsson-Ehle H; Andersson PO;
    Leuk Lymphoma; 2006 Dec; 47(12):2505-16. PubMed ID: 17169795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
    Brenner H; Gondos A; Pulte D
    Blood; 2008 May; 111(10):4916-21. PubMed ID: 18309034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
    Meunier G; Ysebaert L; Nguyen-Thi PL; Lepretre S; Quinquenel A; Dupuis J; Lemal R; Aurran T; Tomowiak C; Cymbalista F; Dilhuydy MS; Brion A; Morel P; Cazin B; Leblond V; Cartron G; Ré D; Béné MC; Michallet AS; Feugier P
    Hematol Oncol; 2017 Dec; 35(4):671-678. PubMed ID: 27878835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
    Soumerai JD; Ni A; Darif M; Londhe A; Xing G; Mun Y; Kay NE; Shanafelt TD; Rabe KG; Byrd JC; Chanan-Khan AA; Furman RR; Hillmen P; Jones J; Seymour JF; Sharman JP; Ferrante L; Mobasher M; Stark T; Reddy V; Dreiling LK; Bhargava P; Howes A; James DF; Zelenetz AD
    Lancet Haematol; 2019 Jul; 6(7):e366-e374. PubMed ID: 31109827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Pavletic ZS; Bierman PJ; Vose JM; Bishop MR; Wu CD; Pierson JL; Kollath JP; Weisenburger DD; Kessinger A; Armitage JO
    Ann Oncol; 1998 Sep; 9(9):1023-6. PubMed ID: 9818078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
    Catovsky D; Fooks J; Richards S
    Br J Haematol; 1989 Jun; 72(2):141-9. PubMed ID: 2757960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia: a retrospective study of 122 cases.
    Erlanson M; Osterman B; Jonsson H; Lenner P
    Eur J Haematol; 1994 Feb; 52(2):108-14. PubMed ID: 8119380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
    Chiattone C; Gomez-Almaguer D; Pavlovsky C; Tuna-Aguilar EJ; Basquiera AL; Palmer L; de Farias DLC; da Silva Araujo SS; Galvez-Cardenas KM; Gomez Diaz A; Lin JH; Chen YW; Machnicki G; Mahler M; Parisi L; Barreyro P
    Hematology; 2020 Dec; 25(1):366-371. PubMed ID: 33095117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
    Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective analysis of 184 cases.
    Sriphatphiriyakun T; Auewarakul CU
    Asian Pac J Allergy Immunol; 2005 Dec; 23(4):197-203. PubMed ID: 16572739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.
    Vicente EP; Cuellar-García C; Martinez M; Soler A; Mora A; Bosch R; Brunet S; Briones J; García I; Esquirol A; Granell M; Saavedra S; Nomdedeu J; Sierra J; Martino R; Moreno C
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):737-742. PubMed ID: 30017595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.